233 related articles for article (PubMed ID: 19414342)
1. RUNX1 translocations in malignant hemopathies.
De Braekeleer E; Férec C; De Braekeleer M
Anticancer Res; 2009 Apr; 29(4):1031-7. PubMed ID: 19414342
[TBL] [Abstract][Full Text] [Related]
2. RUNX1 translocations and fusion genes in malignant hemopathies.
De Braekeleer E; Douet-Guilbert N; Morel F; Le Bris MJ; Férec C; De Braekeleer M
Future Oncol; 2011 Jan; 7(1):77-91. PubMed ID: 21174539
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel Runx1 (AML1) translocation partner genes SH3D19, YTHDf2, and ZNF687 in acute myeloid leukemia.
Nguyen TT; Ma LN; Slovak ML; Bangs CD; Cherry AM; Arber DA
Genes Chromosomes Cancer; 2006 Oct; 45(10):918-32. PubMed ID: 16858696
[TBL] [Abstract][Full Text] [Related]
4. CLCA2, a novel RUNX1 partner gene in a therapy-related leukemia with t(1;21)(p22;q22).
Giguère A; Hébert J
Cancer Genet Cytogenet; 2010 Oct; 202(2):94-100. PubMed ID: 20875871
[TBL] [Abstract][Full Text] [Related]
5. Core binding factor genes and human leukemia.
Hart SM; Foroni L
Haematologica; 2002 Dec; 87(12):1307-23. PubMed ID: 12495904
[TBL] [Abstract][Full Text] [Related]
6. Two novel translocations disrupt the RUNX1 gene in acute myeloid leukemia.
Dai H; Xue Y; Pan J; Wu Y; Wang Y; Shen J; Zhang J
Cancer Genet Cytogenet; 2007 Sep; 177(2):120-4. PubMed ID: 17854666
[TBL] [Abstract][Full Text] [Related]
7. RUNX1 (AML-1) and RUNX2 (AML-3) cooperate with prostate-derived Ets factor to activate transcription from the PSA upstream regulatory region.
Fowler M; Borazanci E; McGhee L; Pylant SW; Williams BJ; Glass J; Davis JN; Meyers S
J Cell Biochem; 2006 Jan; 97(1):1-17. PubMed ID: 16237704
[TBL] [Abstract][Full Text] [Related]
8. Marker chromosomes are a significant mechanism of high-level RUNX1 gene amplification in hematologic malignancies.
Moosavi SA; Sanchez J; Adeyinka A
Cancer Genet Cytogenet; 2009 Feb; 189(1):24-8. PubMed ID: 19167608
[TBL] [Abstract][Full Text] [Related]
9. Expression status of RUNX1/AML1 in normal gastric epithelium and its mutational analysis in microdissected gastric cancer cells.
Usui T; Aoyagi K; Saeki N; Nakanishi Y; Kanai Y; Ohki M; Ogawa K; Yoshida T; Sasaki H
Int J Oncol; 2006 Oct; 29(4):779-84. PubMed ID: 16964375
[TBL] [Abstract][Full Text] [Related]
10. Role of RUNX family members in transcriptional repression and gene silencing.
Durst KL; Hiebert SW
Oncogene; 2004 May; 23(24):4220-4. PubMed ID: 15156176
[TBL] [Abstract][Full Text] [Related]
11. Expression of AML/Runx and ETO/MTG family members during hematopoietic differentiation of embryonic stem cells.
Okumura AJ; Peterson LF; Lo MC; Zhang DE
Exp Hematol; 2007 Jun; 35(6):978-88. PubMed ID: 17533052
[TBL] [Abstract][Full Text] [Related]
12. RUNX genes in development and cancer: regulation of viral gene expression and the discovery of RUNX family genes.
Ito Y
Adv Cancer Res; 2008; 99():33-76. PubMed ID: 18037406
[TBL] [Abstract][Full Text] [Related]
13. Targeting the oligomerization domain of ETO interferes with RUNX1/ETO oncogenic activity in t(8;21)-positive leukemic cells.
Wichmann C; Chen L; Heinrich M; Baus D; Pfitzner E; Zörnig M; Ottmann OG; Grez M
Cancer Res; 2007 Mar; 67(5):2280-9. PubMed ID: 17332359
[TBL] [Abstract][Full Text] [Related]
14. MYND-less splice variants of AML1-MTG8 (RUNX1-CBFA2T1) are expressed in leukemia with t(8;21).
Kozu T; Fukuyama T; Yamami T; Akagi K; Kaneko Y
Genes Chromosomes Cancer; 2005 May; 43(1):45-53. PubMed ID: 15723339
[TBL] [Abstract][Full Text] [Related]
15. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
Harada Y; Harada H
J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
[TBL] [Abstract][Full Text] [Related]
16. Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia.
Osato M
Oncogene; 2004 May; 23(24):4284-96. PubMed ID: 15156185
[TBL] [Abstract][Full Text] [Related]
17. The identification of (ETV6)/RUNX1-regulated genes in lymphopoiesis using histone deacetylase inhibitors in ETV6/RUNX1-positive lymphoid leukemic cells.
Starkova J; Madzo J; Cario G; Kalina T; Ford A; Zaliova M; Hrusak O; Trka J
Clin Cancer Res; 2007 Mar; 13(6):1726-35. PubMed ID: 17325341
[TBL] [Abstract][Full Text] [Related]
18. Identification of a potential "hotspot" DNA region in the RUNX1 gene targeted by mitoxantrone in therapy-related acute myeloid leukemia with t(16;21) translocation.
Ottone T; Hasan SK; Montefusco E; Curzi P; Mays AN; Chessa L; Ferrari A; Conte E; Noguera NI; Lavorgna S; Ammatuna E; Divona M; Bovetti K; Amadori S; Grimwade D; Lo-Coco F
Genes Chromosomes Cancer; 2009 Mar; 48(3):213-21. PubMed ID: 19023877
[TBL] [Abstract][Full Text] [Related]
19. Gatekeeper function of the RUNX1 transcription factor in acute leukemia.
Niebuhr B; Fischer M; Täger M; Cammenga J; Stocking C
Blood Cells Mol Dis; 2008; 40(2):211-8. PubMed ID: 17920312
[TBL] [Abstract][Full Text] [Related]
20. RUNX1-MTG16 fusion gene in acute myeloblastic leukemia with t(16;21)(q24;q22): case report and review of the literature.
De Braekeleer E; Douet-Guilbert N; Le Bris MJ; Morel F; Férec C; De Braekeleer M
Cancer Genet Cytogenet; 2008 Aug; 185(1):47-50. PubMed ID: 18656694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
